CNTN (Canton Strategic Holdings) Net Margin %: 0.00% (As of Mar. 2026)


CNTN Canton Strategic Holdings Inc CNTN
22 GF Score
Price $2.95
! 2 Warning Signs
View Full Analysis

What is Canton Strategic Holdings Net Margin %?

Canton Strategic Holdings CNTN +10.61% 22 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates CNTN with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Canton Strategic Holdings ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Canton Strategic Holdings's Net Income for the three months ended in Mar. 2026 was $-47.34 Mil. Canton Strategic Holdings's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Canton Strategic Holdings's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Canton Strategic Holdings's Net Margin % or its related term are showing as below:


CNTN's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Canton Strategic Holdings  (NAS:CNTN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Canton Strategic Holdings Net Margin % Related Terms

Canton Strategic Holdings Net Margin % Historical Data

* Premium members only.

The historical data trend for Canton Strategic Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canton Strategic Holdings Net Margin % Chart

Canton Strategic Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Canton Strategic Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CNTN vs ELTX, NGEN, NBP: Net Margin % Comparison

For the Biotechnology subindustry, Canton Strategic Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Canton Strategic Holdings Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Canton Strategic Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Canton Strategic Holdings's Net Margin % falls into.


CNTN
22GF Score
Canton Strategic Holdings Inc CNTN
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Canton Strategic Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Canton Strategic Holdings's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-35.916/0
= %

Canton Strategic Holdings's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-47.343/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Canton Strategic Holdings (CNTN) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Canton Strategic Holdings and its competitors. According to the industry distribution chart, Canton Strategic Holdings ranks #999999 out of 946 companies in the Biotechnology industry.
Is Canton Strategic Holdings' Net Margin % too high?
Canton Strategic Holdings' current Net Margin % is 0.00%. Based on the distribution chart, Canton Strategic Holdings ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Canton Strategic Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Canton Strategic Holdings' Net Margin % compare to ELTX and NGEN?
According to the Biotechnology industry distribution chart, Canton Strategic Holdings ranks #999999 out of 946 companies for Net Margin %. This places Canton Strategic Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Canton Strategic Holdings and its competitors. Canton Strategic Holdings's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Canton Strategic Holdings stock overvalued right now?
Canton Strategic Holdings (CNTN) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Canton Strategic Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Canton Strategic Holdings (CNTN), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Canton Strategic Holdings Business Description

Address 34 Shrewsbury Avenue, Suite 1C, Red Bank, NJ, USA, 07701
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
22GF Score

Get the complete analysis for CNTN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.95
Price